Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer (Q63199409)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8026259 AND SRC:MED&resulttype=core&format=json

23 October 2019

title

Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8026259 AND SRC:MED&resulttype=core&format=json

23 October 2019

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8026259 AND SRC:MED&resulttype=core&format=json

23 October 2019

author name string

V Savarino

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8026259 AND SRC:MED&resulttype=core&format=json

23 October 2019

G S Mela

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8026259 AND SRC:MED&resulttype=core&format=json

23 October 2019

P Cutela

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8026259 AND SRC:MED&resulttype=core&format=json

23 October 2019

M R Mele

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8026259 AND SRC:MED&resulttype=core&format=json

23 October 2019

D Perilli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8026259 AND SRC:MED&resulttype=core&format=json

23 October 2019

A Vassallo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8026259 AND SRC:MED&resulttype=core&format=json

23 October 2019

A Zambotti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8026259 AND SRC:MED&resulttype=core&format=json

23 October 2019

C Mansi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8026259 AND SRC:MED&resulttype=core&format=json

23 October 2019

G Celle

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8026259 AND SRC:MED&resulttype=core&format=json

23 October 2019

publication date

1 July 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8026259 AND SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

23 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8026259 AND SRC:MED&resulttype=core&format=json

23 October 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8026259 AND SRC:MED&resulttype=core&format=json

23 October 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8026259 AND SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

1473-1482

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8026259 AND SRC:MED&resulttype=core&format=json

Variability in individual response to various doses of omeprazole

23 October 2019

cites work

1 reference

12 December 2020

1 reference

12 December 2020

Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report on 413 cases

1 reference

12 December 2020

Continuous 24 hour intragastric pH monitoring: focus on reproducibility in duodenal ulcer patients. A preliminary report

1 reference

12 December 2020

Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer

1 reference

12 December 2020

Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders

1 reference

12 December 2020

Antimony and glass pH electrodes can be used interchangeably in 24-hour studies of gastric acidity

1 reference

12 December 2020

Cure of duodenal ulcer associated with eradication of Helicobacter pylori

1 reference

12 December 2020

The protective role of gastric acid

1 reference

12 December 2020

Nine years of maintenance treatment with ranitidine for patients with duodenal ulcer disease

1 reference

12 December 2020

Tolerance to oral H2-receptor antagonists

1 reference

12 December 2020

Gastric Aspiration versus Antimony and Glass pH Electrodes: A Simultaneous Comparative in Vivo Study

1 reference

12 December 2020

Economic and health aspects of peptic ulcer disease and H2-receptor antagonists

1 reference

12 December 2020

Continuous acidity monitoring in the study of gastric antisecretory drugs: pH or antilog transformation of pH, mean or median?

1 reference

12 December 2020

Clinical significance of hypergastrinaemia: relevance to gastrin monitoring during omeprazole therapy

1 reference

12 December 2020

Long-Term Omeprazole Treatment in Man: Effects on Gastric Endocrine Cell Populations

1 reference

12 December 2020

Relationship between ulcer healing and acid suppression

1 reference

12 December 2020

Ulcer healing: does omeprazole efficacy depend on daytime or 24-hour acid inhibition?

1 reference

12 December 2020

Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin

1 reference

12 December 2020

Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man

1 reference

12 December 2020

Effects of low dose omeprazole on gastric secretion and plasma gastrin in patients with healed duodenal ulcer

1 reference

12 December 2020

Effect of 'weekend therapy' with omeprazole on basal and stimulated acid secretion and fasting plasma gastrin in duodenal ulcer patients

1 reference

12 December 2020

Weekend treatment with 20 and 40 mg omeprazole: effect on intragastric pH, fasting and postprandial serum gastrin, and serum pepsinogens

1 reference

12 December 2020

Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole

1 reference

12 December 2020

Helicobacter pylori and peptic ulcer disease

1 reference

12 December 2020

Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole

1 reference

12 December 2020

Maintenance treatment with H2 receptor antagonists in patients with peptic ulcer disease: rarely justified in terms of cost or patient benefit

1 reference

12 December 2020

Omeprazole 20 mg three days a week and 10 mg daily in prevention of duodenal ulcer relapse. Double-blind comparative trial

1 reference

12 December 2020

Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity

1 reference

12 December 2020

Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment

1 reference

12 December 2020

Effect of repeated, once daily, oral omeprazole on gastric secretion

1 reference

12 December 2020

Low dose omeprazole effects on gastric acid secretion in normal man.

1 reference

12 December 2020

Current status of maintenance therapy in peptic ulcer disease. The ACG Committee on FDA-Related Matters

1 reference

12 December 2020

Prevention of Relapse of Reflux Esophagitis after Endoscopic Healing: The Efficacy and Safety of Omeprazole Compared with Ranitidine

1 reference

12 December 2020

Review article: maintenance treatment with H2-receptor antagonists for peptic ulcer disease

1 reference

12 December 2020

24-H comparison between pH values of continuous intraluminal recording and simultaneous gastric aspiration

1 reference

12 December 2020